SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-201877
Filing Date
2012-05-02
Accepted
2012-05-01 20:35:36
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d334305d10q.htm 10-Q 570181
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d334305dex311.htm EX-31.1 9041
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d334305dex312.htm EX-31.2 9229
4 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d334305dex321.htm EX-32.1 4988
  Complete submission text file 0001193125-12-201877.txt   2032814

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arna-20120331.xml EX-101.INS 212629
6 XBRL TAXONOMY EXTENSION SCHEMA arna-20120331.xsd EX-101.SCH 12570
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20120331_cal.xml EX-101.CAL 37306
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20120331_def.xml EX-101.DEF 33418
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20120331_lab.xml EX-101.LAB 111162
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20120331_pre.xml EX-101.PRE 78788
Mailing Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121 8584537200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 12802413
SIC: 2834 Pharmaceutical Preparations